Stay updated on IMM-101 Combo with Checkpoint Inhibitor in Melanoma Clinical Trial
Sign up to get notified when there's something new on the IMM-101 Combo with Checkpoint Inhibitor in Melanoma Clinical Trial page.

Latest updates to the IMM-101 Combo with Checkpoint Inhibitor in Melanoma Clinical Trial page
- ChecktodayChange DetectedMelanoma is removed from the page's conditions list, and MedlinePlus Genetics is removed from related topics.SummaryDifference0.2%

- Check7 days agoNo Change Detected
- Check15 days agoChange DetectedMelanoma and MedlinePlus Genetics were added to the related topics section.SummaryDifference0.2%

- Check22 days agoChange DetectedRevision: v3.5.0 added; Melanoma and related topics (MedlinePlus Genetics) and Revision: v3.4.3 were removed.SummaryDifference0.2%

- Check29 days agoChange DetectedAdded Melanoma as a related topic and a MedlinePlus Genetics link; updated the revision from v3.4.2 to v3.4.3.SummaryDifference0.2%

- Check57 days agoChange DetectedAdded Revision: v3.4.2 and removed the prior notices for funding/operating status (Revision: v3.4.1).SummaryDifference0.4%

- Check65 days agoChange DetectedAdded a site-wide funding notice and updated the site version to v3.4.1, replacing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to IMM-101 Combo with Checkpoint Inhibitor in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMM-101 Combo with Checkpoint Inhibitor in Melanoma Clinical Trial page.